Skip to main content
SpringerLink
Log in

Mitoxantrone-treated MS patients: beware acute leukaemia

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rammohan K, Kita M, Lynn D, Dawson D, Bennett R, Al-Sabbagh A.Post-marketing reports of acute leukemia in mitoxantrone-treated multiple sclerosis patients. World Congress on Treatment and Research in Multiple Sclerosis: abstr. P497, 17 Sep 2008. Available from: URL: http://www.msmontreal.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitoxantrone-treated MS patients: beware acute leukaemia. React. Wkly. 1223, 3 (2008). https://doi.org/10.2165/00128415-200812230-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812230-00008

Keywords

Search

Navigation